working draft

below are some of the comments that have been made during the last few months and also some questions, I also a a PM from one of you which i will put up in another post

This is just a working draft to get some juices flowing as you are all very quiet

Please feel free to add or make comments, this has all been C&P from the thread

• POH should issue monthly market updates - that would be great
• Ms OGRU has said 42 coys. How many companies are POH in meaningful commercial discussions with?
• The last stand-alone Phospha E announcement was in Nov 2008 - we have had to glean details from reports, presentations and newsletters since then. In Nov 08 we were told that the company 'expected to have results by the end of the first quarter of 2009'. In the Annual Report, which I think was written in mid February, we were advised 'results expect to be announced at the end of 1Q or early 2Q of 2009'. At the AGM at the end of May, it was intimated that results could be available by mid July.

It surely can't have taken this long to complete the analysis - remember those 6 week time frames given by the company. If the results are available shouldn't they be announced to the market as soon as possible? Nestle deciding what to do about those results is a separate matter that should be announced separately.
• Dr OGRU has said that they are having a Major Launch of their 6 product cosmetic range in Oz in FEB10. Is this still on track?
• There has been no explanation for the SPP other than it is for working capital i.e. routine expenses. Why did they do it? Is it because management realizes that it's last drinks at the Last Chance Saloon?
• Negatives in no particular priority listing.
1. Marketing.
2. Communication (to shareholders, the market and potential partners/buyers of the technology).
3. Missing stated target dates/timelines.
4. Lack of focus/concentration on specific projects.
• the problem with POH is the lack of investor update. When was the last time we were updated on Nestle and CSL. They should update even if all they say is STILL IN PROGRESS.I
• update and timeframes on Nestle
• are they going to go hard on one drug in the pipeline and push it through to completion
• The "market darling" Bios like ACL,BTA,OBJ,UNI (there are many others) have all released numerous announcements of their ongoing activities. Take a look at the announcements on the company threads - and have a look at their ever rising SP's to go with them.

What news from POH during this time? A re-release of the Le Metier announcement
• We think Vizard needs to go. Agriculture credentials are no match for the big boys who pull the strings in the pharma industry.
Look at where Acrux went to when they got rid of the old school and moved Treagus in. Company had a new focus, value added to its core business and SP went up where it should be.
Second to go is BBY. Acrux has also recently appointed Credit Swisse (6 Nov) because they realised that is the advanced stages of commercialisation of its products that they needed someone with some better reach and better credentials.
• At the time of the Agm the SP was 0.14 today 0.077, during the AGM Prof Vizard as Chairman asked for our patience, Please explain why we shouldn’t move a no confidence motion against him as chairman, Might be time for some new blood on the board, may be that a fresh chairman would be good,
•